4-Year Follow-up in a Child with a Total Autologous Tracheal Replacement
Frédéric Kolb(Scripps Research Institute), Éréa-Noël Garabédian(Inserm), Briac Thierry(Hôpital Necker-Enfants Malades), Régis Gaudin(Hôpital Necker-Enfants Malades), Françoise Denoyelle(Hôpital Necker-Enfants Malades), Vincent Couloigner(Hôpital Necker-Enfants Malades), Nicolas Leboulanger(Hôpital Necker-Enfants Malades), Laurent Dupic(Hôpital Necker-Enfants Malades), Sacha Mussot(Centre Chirurgical Marie Lannelongue), Jean-Louis Coste(Hôpital Necker-Enfants Malades), François Simon
Cited by 20
Related Papers
GJB2 Mutations and Degree of Hearing Loss: A Multicenter Study
|The American Journal of Human Genetics|2005|558
Role of Propranolol in the therapeutic strategy of infantile laryngotracheal hemangioma
|International Journal of Pediatric Otorhinolaryngology|2009|235
Langerhans cell histiocytosis: therapeutic strategy and outcome in a 30‐year nationwide cohort of 1478 patients under 18 years of age
|British Journal of Haematology|2016|130
A Case of Respiratory Depression in a Child With Ultrarapid CYP2D6 Metabolism After Tramadol
|PEDIATRICS|2015|113
Propranolol in the therapeutic strategy of infantile laryngotracheal hemangioma: A preliminary retrospective study of French experience
|International Journal of Pediatric Otorhinolaryngology|2010|110